Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Open Forum Infectious Diseases|August 2, 2021
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking EraMounzer E Agha, Maggie Blake, Charles Chilleo, et al.Blood Reviews|May 12, 2023
Failure of CAR-T cell therapy in relapsed and refractory large cell lymphoma and multiple myeloma: An urgent unmet needYasmine St Martin, Joseph K Franz, Mounzer E Agha, et al.Journal of Neuropathology and Experimental Neurology|September 21, 2020
Multifocal Necrotizing Leukoencephalopathy With Preferential Microglia Toxicity in a Patient Treated With Chimeric Antigen Receptor T-Cells and Review of the LiteratureDaniel F Marker, Julia K Kofler, Joseph A Mettenburg, et al.American Journal of Infection Control|July 23, 2013
Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patientsYuriko Fukuta, Robert R Muder, Mounzer E Agha, et al.Diagnostic Pathology|August 5, 2022
Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphomaVandana Baloda, Sarah E Wheeler, David L Murray, et al.Cancer Treatment and Research Communications|March 19, 2026
Systematic literature review of secondary primary malignancies related to a CAR-T treatment in patients with multiple myeloma, lymphoma or leukemiaMounzer E Agha, Sarah McGregor, Kevin C De Braganca, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2021
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case StudyMatthew K Hensley, William G Bain, Jana Jacobs, et al.The New England Journal of Medicine|June 6, 2022
Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaPaul G Richardson, Susanna J Jacobus, Edie A Weller, et al.Pageof 1